| Application no. and date | 12824342.5 (espacenet) (Federated) (European Patent Register), 20120815 | | Patent/reg. no. and date | DK/EP 2746404, 20171206 | | Publication date | 20140625 | | Priority no. and date | JP 2011177838, 20110816 | | EP pub. no. and date |
EP 2746404 20140625 | | Effective date | | | Applicant/owner | Taiho Pharmaceutical Co., Ltd., 1-27, Kandanishiki-cho
Chiyoda-ku, Tokyo 101-8444, JP | | Applicant ref. no. | P63318DK01 | | Inventor | ITO, Masanobu, c/o TAIHO PHARMACEUTICAL CO., LTD.
1-27 Kandanishiki-cho
Chiyoda-ku
Tokyo 101-8444, JP,
OKABE, Hiroyuki, c/o TAIHO PHARMACEUTICAL CO., LTD.
3 Okubo
Tsukuba-shi
Ibaraki 300-2611, JP | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/513 (2006.01) , A61K 31/7072 (2006.01) , A61P 1/00 (2006.01) , A61P 35/00 (2006.01) , C12Q 1/68 (2006.01) | | Title | ANTITUMORMIDDEL OG FREMGANGSMÅDE TIL FORUDSIGELSE AF TERAPEUTISK EFFEKT FOR PATIENTER MED KRAS-MUTERET KOLOREKTAL CANCER | | Int. application no. | JP2012070745 | | Int. publication no. | WO2013024865 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
